Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Retraction
IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Retraction]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 2,662 | Dovepress* | 2,590+ | 136 | 2,726 | |
| PubMed Central* | 72 | 30 | 102 | ||
| Totals | 2,662 | 166 | 2,828 | ||
| *Since 22 August 2022 | |||||
View citations on PubMed Central and Google Scholar